Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases

Brazilian Journal of Microbiology

Volumn 41, Issue 2, 2010, Pages 333-344

  Gad, Gamal Fadl M ^a   Abd El Ghafar, Abd El Ghafar F ^b   El Domany, Ramadan A A ^c   Hashem, Zeinab Shawky ^a  

^a Minia University   (Egypt)

^b Minia University   (Egypt)

^c Helwan   (Egypt)

Author keywords

CCCP; DAA technique; Efflux; Fluorometric assay; lactamase

Indexed keywords

MEASLES VIRUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 77951000972     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822010000200012     Document Type: Article

References (37)

1. Aeschlimann, J.R.; Kaatz, G.W.; Rybak, M.J. (1999). The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model. J Antimicrob Chemother., 44(3), 343-349.
2. Alexander, S.T.; Strele, D.; Niles, M.J. (2004). Laboratory exercises in organismal and molecular microbiology. Mc. Grow Hill, USA.
3. Archer, G.L. (1998). Staphylococcus aureus: A well-armed pathogen. Clin Infect Dis, 26, 1179-1181.
4. Arslan, S.; Ozkarde, F. (2007). Slime production and antibiotic susceptibility in staphylococci isolated from clinical samples. Mem Inst Oswaldo Cruz., 102(1), 29-33.
5. Bashir, A.; Mujahid, T.Y.; Jehan, N. (2007). Antibiotic resistance profile: isolation and characterization of clinical isolates of staphylococci from patients with community-acquired skin infections. Pak J Pharm Sci., 20(4), 299-304.
6. Boneca, I.G.; Chiosis, G. (2003). Vancomycin resistance: occurrence, mechanisms and strategies to combat it. Expert Opin Ther Targets, 7, 311-328.
7. Bonfiglio, G.; Livermore, D.M. (1994).β-lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to β -lactam inhibitor combinations. Antimicrob. Chemother., 33, 465-81.
8. Casey, A.L.; Lambert, P.A.; Elliott, T.S.J. (2007). Staphylococci. Int J Antimicrob Agents, 29 (Suppl.3), 23-32.
9. Chapman, J.S.; Georgopapadakou, N.H. (1989). Fluorometric assay for fleroxacin uptake by bacterial cells. Antimicrob. Agents Chemother., 33(1), 27-29.
10. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests, 9th ed. Approved. M2-A9 (2006). Clin. Lab. Stand. Inst., 26 (1), 1-172.
11. Collee, J.G.; Fraser, A.G.; Marmion, B.P.; Simmons, A. (1996). Tests for identification of bacteria. In: Mackie & McCartney. Practical medical microbiology. New York, USA.
12. Elouennass, M.; Sahnoun, I.; Zrara, A.; Bajjou, T.; Elhamzaoui, S. (2008). Epidemiology and susceptibility profile of blood culture isolates in an intensive care unit (2002-2005). Med Mal Infect, 38(1), 18-24.
13. Ferrara, A.; Dos-Santos, C.; Cimbro, M.; Gialdroni Grassi, G. (1997). Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci. Eur J Clin Microbiol Infect Dis., 16(7), 535-537.
14. Firth, N.; Apisiridej, S.; Berg, T.; O'Rourke, B.A.; Curnock, S.; Dyke, G.H.K.; Skurray, R.A. (2000). Replication of Staphylococcal Multiresistance Plasmids. J. Bacteriol., 182, 2170-2178.
15. Jain, A.; Agarwa, J.; Bansal, S. (2004). Prevalence of methicillin- resistant, coagulase-negative staphylococci in neonatal intensive care units: findings from a tertiary care hospital in India. J Med Microbiol, 53, 941-944.
16. Jenkins, S.G.; Lewis, J.W. (1995). Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens. Infection, 23(4): 245.
17. Kaatz, G.W.; Seo, S.M.; Ruble, C.A. (1991). Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. Journal of infectious diseases., 163, 1080-1086.
18. Khosravi, A.D.; Mehdinejad, M.; Heidari, M. (2007). Bacteriological findings in patients with ocular infection and antibiotic susceptibility patterns of isolated pathogens. Singapore Med J., 48(8), 741-743.
19. Knauer, A.; Fladerer, P.; Strempfl, C. (2004). Effect of hospitalization and antimicrobial therapy on bantimicrobial resistance of colonizing Staphylococcus epidermidis. Wien Klin Wochenschr, 116, 489-494.
20. Le Loir, Y.; Baron, F.; Gautier, M. (2003). Staphylococcus aureus and food poisoning. Genet Mol Res., 2(1), 63-7.
21. Liang, W.; Huang, H.; Lin, R.; Hou, W. (2003). Screening for natural inhibitors of penicillinase by copolymerization of hydrolyzed starch or glycogen in sodium dodecylsulfate polyacrylamide gels for detecting penicillinase activity. Bot. Bull. Acad. Sin., 44, 187-191.
22. Lynch, A.S. (2006). Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. Biochem Pharmacol., 71(7): 949-956.
23. Mansouri, S. and Khalegi, M. (1997). Antibacterial resistance pattern and frequency of methicillin resistant Staphylococcus aureus isolated from different sources in Southern Iran. Am. J. Med. Sci., 22, 89-93.
24. Marquez, B. (2005). Bacterial efflux systems and efflux pumps inhibitors. Biochimie., 87(12), 1137-1147.
25. Nayak, N.; Satpathy, G.; Vajpayee, R.B.; Mrudula, S. (2007). Phenotypic and plasmid pattern analysis of Staphylococcus epidermidis in bacterial keratitis. Indian J Ophthalmol., 55(1), 9-13.
26. Nworu, C.S.; Esimone, C.O. (2006). Comparative Evaluation of Three In Vitro Techniques in the Interaction of Ampicillin and Ciprofloxacin against Staphylococcus aureus and Escherichia coli. Tropical Journal of Pharmaceutical Research, 5(2), 605-611.
27. Palazzo, I.C.V.; Araujo, M.L.C.; Darini, A.L.C. (2005). First report of vancomycin-resistant Staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol, 43, 179-185.
28. Piddock, L.J.; Jin, Y.F.; Griggs, D.J. (2001). Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus. J Antimicrob Chemother., 47(3), 261-270.
29. Piddock, L.J.; Jin, Y.F.; Webber, M.A.; Everett, M.J. (2002). Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus. Antimicrob Agents Chemother., 46(7), 2276-2278.
30. Rayner, C.; Munckhof, W.J. (2006). Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern Med J., 36(2), 142-143.
31. Sabath, L.D. (1982). Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus. Ann Intern Med, 97(3), 339-344.
32. Sanders, C.C.; Sanders, W.E.; Moland, E.S. (1993). Decimal assay for additivity of drugs permits delineation of synergy and antagonism. Antimicrob Agents Chemother., 37(2), 260-264.
33. Shakibaie, M.R.; Mansouri, S.; Hakak, S. (2002). Plasmid pattern of antibiotic resistance in beta-lactamase producing Staphylococcus aureus strains isolated from hospitals in Kerman, Iran. Am. J. Med. Sci., 27, 80-83.
34. Skov, R.; Frimodt-Moller, N.; Espersen, F. (2003). Tentative interpretative zone diameters for fusidic Neosensitabs† on Mueller Hinton agar and three blood media. Int J Antimicrob Agents, 22, 502-507.
35. Sykes, R.B. (1978). Methods for detecting -lactamases. In: Reeves, D.S.; Phillips, I.; Williams, J.D.; Wise, R. (eds). Laboratory methods in Antimicrobial Chemotherapy. Mulligan, Churchill Livingstone, p. 64-69.
36. Takenouchi, T.; Tabata, F.; Iwata, Y.; Hanzawa, H.; Sugawara, M.; Ohya, S. (1996). Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother., 40, 1835-1842.
37. Winn, W.C.; Allen, S.D.; Janda, W.M.; Koneman, E.W.; Procop, G.W.; Schreckenberger, P.C.; Woods, G.L. (2006). Color Atlas Textb. Diagn. Microbiol., New York, USA.